Literature DB >> 15585605

Toll-like receptors in innate immunity.

Kiyoshi Takeda1, Shizuo Akira.   

Abstract

Functional characterization of Toll-like receptors (TLRs) has established that innate immunity is a skillful system that detects invasion of microbial pathogens. Recognition of microbial components by TLRs initiates signal transduction pathways, which triggers expression of genes. These gene products control innate immune responses and further instruct development of antigen-specific acquired immunity. TLR signaling pathways are finely regulated by TIR domain-containing adaptors, such as MyD88, TIRAP/Mal, TRIF and TRAM. Differential utilization of these TIR domain-containing adaptors provides specificity of individual TLR-mediated signaling pathways. Several mechanisms have been elucidated that negatively control TLR signaling pathways, and thereby prevent overactivation of innate immunity leading to fatal immune disorders. The involvement of TLR-mediated pathways in autoimmune and inflammatory diseases has been proposed. Thus, TLR-mediated activation of innate immunity controls not only host defense against pathogens but also immune disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585605     DOI: 10.1093/intimm/dxh186

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  957 in total

1.  Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.

Authors:  Tae Whan Kim; Minjia Yu; Hao Zhou; Wei Cui; Jianan Wang; Paul DiCorleto; Paul Fox; Hui Xiao; Xiaoxia Li
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells.

Authors:  Deepthi Kolli; Xiaoyong Bao; Tianshuang Liu; Chao Hong; Tian Wang; Roberto P Garofalo; Antonella Casola
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

3.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

4.  Domain combination of the vertebrate-like TLR gene family: implications for their origin and evolution.

Authors:  Baojun Wu; Tianxiao Huan; Jing Gong; Pin Zhou; Zengliang Bai
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

5.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

6.  Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases.

Authors:  Qinzhong Chen; Sanjay Gupta; Alessandra B Pernis
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

Review 7.  Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll-like receptors 2 and 4.

Authors:  C P C Marques; Y Maor; M S de Andrade; V P Rodrigues; B B Benatti
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 8.  Trp channels and itch.

Authors:  Shuohao Sun; Xinzhong Dong
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

9.  The central adaptor molecule TRIF influences L. sigmodontis worm development.

Authors:  Anna Wiszniewsky; Manuel Ritter; Vanessa Krupp; Sandy Schulz; Kathrin Arndts; Heike Weighardt; Samuel Wanji; Achim Hoerauf; Laura E Layland
Journal:  Parasitol Res       Date:  2019-01-15       Impact factor: 2.289

10.  KH-type splicing regulatory protein is regulated by nuclear factor-κB signaling to mediate innate immunity in Caco-2 cells infected by Salmonella enteritidis.

Authors:  Yuanyang Nie; Mei Cao; Daoyan Wu; Ningzhe Li; Jingshan Peng; Sijun Yi; Xiaofan Yang; Mao Zhang; Guoku Hu; Jian Zhao
Journal:  Folia Microbiol (Praha)       Date:  2018-05-04       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.